Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.125.323355 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Daniela Grimaldi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Circadian and Sleep Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: Circadian Rhythm, Intermittent Fasting, Obesity, Sleep. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Time-restricted eating has gained attention for its potential cardiometabolic health benefits. Existing time-restricted eating approaches may have limited adherence and sustainability due to fixed fasting windows with prolonged fasting duration before sleep, or they involve self-selected fasting windows without specifying the duration relative to sleep, a critical period for cardiometabolic regulation. We hypothesized that an individualized approach that extended overnight fasting duration by 3 hours in alignment with habitual sleep time (last meal ≥3 hours before sleep) would enhance nighttime autonomic balance, decrease blood pressure and heart rate, increase blood pressure per hour dipping, and glucose regulation compared with a control group maintaining habitual eating patterns. METHODS: In this randomized parallel-arm controlled trial, 39 overweight/obese participants (36–75 years) completed either an extended overnight fasting intervention (13–16-hour fasting) or a control condition (habitual fast of 11–13 hours). Both groups dimmed lights 3 hours before bedtime. The intervention duration was 7.5 weeks. RESULTS: Compared with control, extended overnight fasting intervention significantly improved the coprimary outcome of nighttime dipping of diastolic blood pressure, but not the Matsuda Index of insulin sensitivity. extended overnight fasting improved secondary measures of nighttime autonomic function and morning oral glucose tolerance, including lower nighttime heart rate, higher heart rate variability, lower nighttime cortisol, and during the Oral Glucose Tolerance Test, lower glucose level, and higher 30-minute insulinogenic index, indicating improved acute insulin response. CONCLUSIONS: Extending overnight fasting duration by 3 hours in alignment with sleep improved cardiometabolic health in middle-aged/older adults by strengthening coordination between circadian- and sleep-regulated autonomic and metabolic activity. This sleep-aligned time-restricted eating approach represents a novel, accessible lifestyle intervention with promising potential for improving cardiometabolic function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Center for Circadian and Sleep Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
ORCID-Profile: Daniela Grimaldi, Kathryn J Reid, Sabra M Abbott, Kristen L Knutson
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Grimaldi, D., Reid, K. J., Abbott, S. M., Knutson, K. L., & Zee, P. C. (2026). Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323355
Vancouver
Grimaldi D, Reid KJ, Abbott SM, Knutson KL, Zee PC. Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323355
BibTeX
@article{Grimaldi2026,
author = {Grimaldi, Daniela and Reid, Kathryn J and Abbott, Sabra M and Knutson, Kristen L and Zee, Phyllis C},
title = {Sleep-Aligned Extended Overnight Fasting Improves Nighttime and Daytime Cardiometabolic Function},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.125.323355}
}
EUVIMED